<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pharmateca</journal-id><journal-title-group><journal-title xml:lang="en">Pharmateca</journal-title><trans-title-group xml:lang="ru"><trans-title>Фарматека</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2073-4034</issn><issn publication-format="electronic">2414-9128</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">289707</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">HEEL PREPARATIONS IN THE COMPLEX THERAPY OF OSTEOARTHROSIS</article-title><trans-title-group xml:lang="ru"><trans-title>ПРЕПАРАТЫ HEEL В КОМПЛЕКСНОЙ ТЕРАПИИ ОСТЕОАРТРОЗА</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zotkin</surname><given-names>E. G</given-names></name><name xml:lang="ru"><surname>Зоткин</surname><given-names>Е. Г</given-names></name></name-alternatives><bio xml:lang="en"><p>MD, Prof., FSBEI HE «North-Western State Medical University n.a. I.I. Mechnikov» of RMH</p></bio><bio xml:lang="ru"><p>д.м.н., проф.</p></bio><email>ezotkin@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2016-11-15" publication-format="electronic"><day>15</day><month>11</month><year>2016</year></pub-date><volume>23</volume><issue>3S</issue><issue-title xml:lang="en">NOs3 (2016)</issue-title><issue-title xml:lang="ru">№s3 (2016)</issue-title><fpage>30</fpage><lpage>34</lpage><history><date date-type="received" iso-8601-date="2023-02-26"><day>26</day><month>02</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2016, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2016, ООО «Бионика Медиа»</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/2073-4034/article/view/289707">https://journals.eco-vector.com/2073-4034/article/view/289707</self-uri><abstract xml:lang="en"><p>Despite the fact that there are many drugs with different mechanisms of action for the pain relief in osteoarthritis, none of them have an absolute efficiency. Along with well-known traditional methods of treatment of OA, which are usually used in accordance with national clinical guidelines and protocols of management of patients, there are alternative methods. Phytotherapy is one of such methods, which is widely used in various joint diseases. Currently, the multicomponent drugs known as Zeel T and Traumeel S, are manufactured for practical application in different forms.</p></abstract><trans-abstract xml:lang="ru"><p>Несмотря на то что для купирования болевого синдрома при остеоартрозе существует масса лекарственных средств с различными механизмами действия, не одно из них не обладает абсолютной эффективностью. Наряду с известными традиционными методами лечения ОА, которые принято использовать в соответствии с национальными клиническими рекомендациями и протоколами ведения пациентов, существуют альтернативные воздействия. К одному из таких методов относят фитотерапию, которая широко применяется при различных заболеваниях суставов. В настоящее время для практического применения выпущены многокомпонентные препараты, получившие название Цель Т и Траумель С, в различных формах.</p></trans-abstract><kwd-group xml:lang="en"><kwd>active ageing</kwd><kwd>osteoarthrosis</kwd><kwd>nonsteroidal antiinflammatory drugs</kwd><kwd>phytotherapy</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>активная старость</kwd><kwd>остеоартроз</kwd><kwd>нестероидные противовоспалительные средства</kwd><kwd>фитотерапия</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>http://www.gks.ru/wps/wcm/connect/ rosstat_main/rosstat/ru/statistics/population/ demography/</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Распоряжение Правительства Российской Федерации от 5 февраля 2016 г. № 164-р «Стратегия действий в интересах граждан старшего поколения в Российской Федерации до 2025 года».</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Стратегии и приоритетные вмешательства по обеспечению здорового старения. Всемирная организация здравоохранения. 2012. 18 с.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Centers for Disease Control and Prevention. Percent of US adults 55 and over with chronic conditions. Sept 2009. http://www.cdc.gov/ nchs/data/health_policy/ adult_chronic_ conditions.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Regnaux J.P., Lefevre-Colau M.M., Trinquart L. High-intensity versus low-intensity physical activity or exercise in people with hip or knee osteoarthritis. Cochrane Database Syst. Rev. 2015;(10):CD010203.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Fransen M., McConnell S., Harmer A.R., et al. Exercise for osteoarthritis of the knee. Cochrane Database Syst. Rev. 2015;(1):CD004376.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Hochberg M.C., Altman R.D., April K.T., et al. American College of Rheumatology 2012 Recommendations for the Use of Nonpharmacologic and Pharmacologic Therapies in Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res.2012;64(4):465-74.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>McAlindon T.E., Bannuru R.R., Sullivan M.C., et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis and Cartilage.2014;22:363-88.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Porozov S., Cahalon L., Weiser M., et al. Inhibition of IL-1ß and TNF-а secretion from resting and activated human immunocytes by the homeopathic medication Traumeel S. Clin. Dev. Immunol. 2004;11(2):143-49.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Heine H., Andrä F. The antiinflammatory action mechanism of an antihomotoxic composite remedy. Arztezeitschrift fur Naturheilverfahren. 2002;43:96-104.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Schneider C. Traumeel - an emerging option to nonsteroidal anti-inflammatory drugs in the management of acute musculoskeletal injuries. Intern. J. General Med.2011;4:225-34.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Lozada C., del Rio E., Reitberg D., et al. A multicenter double-blind, randomized, controlled trial (db-RCT) to evaluate the effectiveness and safety of co-administered TraumeelR (Tr14) and ZeelR (Ze14) intra-articular (IA) injections versus IA placebo in patients with moderate-to-severe pain associated with OA of the knee. Arthritis Rheumatol. 2014;66(Suppl.):S1266.</mixed-citation></ref></ref-list></back></article>
